FDA inspection
Mark Adaimy MD: FDA inspection ending Nov 16, 2020
FDA inspection 1133176 · Voluntary Action Indicated (VAI) · Las Vegas, NV
Key facts
| Inspection ID | 1133176 |
|---|---|
| Firm | Mark Adaimy MD |
| FEI number | 3017124328 |
| Address | 2820 W Charleston Blvd Ste 33 |
| City | Las Vegas |
| State | NV |
| ZIP | 89102 |
| Country | United States |
| Fiscal year | 2021 |
| Inspection end date | Nov 16, 2020 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data